NCT03678597已完成不适用
Latrunculin B Supplementation to ICSI Handling Medium
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 5
- 主要终点
- oocyte survival rate after ICSI
研究概览
简要总结
Vienna Consensus has identified 10% damage rate after ICSI as a competency value. Despite the highest quality embryologists doing ICSI, degeneration sometimes occurs due to oocyte factors such as the fragile membrane, etc. Latrunculin B serves to facilitate spindle or pronuclear transfer procedures helping to reduce the damage rate with no harm reported. Using Latrunculin B during ICSI could serve to rescue some oocytes from the degeneration allowing for more chances of viable zygotes,
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 42 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •All ICSI cycles
排除标准
- 未提供
研究组 & 干预措施
Handling Medium Supplemented with Latrunculin B
Experimental
干预措施: Medium Supplemented with Latrunculin B (Other)
handling Medium as it is.
No Intervention
结局指标
主要结局
oocyte survival rate after ICSI
时间窗: 6 days of culture
次要结局
- Fertilisation rate(6 days of culture)
- Rates of blastocyst formation and quality(6 days of culture)
- Implantation rate(7 weeks)
- Clinical pregnancy rate(three months)
- Ongoing pregnancy rate(12 weeks)
研究者
Muhammad Fawzy
IVF Lab Director
Ibn Sina Hospital
研究点 (5)
Loading locations...
相似试验
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)InfertilityNCT03678818Ibn Sina Hospital300
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin BInfertilityNCT03663634Ibn Sina Hospital987
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)InfertilityNCT03678584Ibn Sina Hospital300
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)InfertilityNCT03677492Ibn Sina Hospital300
撤回
不适用
Anticoagulation in Blunt Cerebrovascular InjuriesCarotid Artery InjuryVertebral Artery InjuryNCT00494156C. Clay Cothren, MD